Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06615076 · ClinicalTrials.gov registry record · NA

Enhancing Care & Outcomes for Patients During the First Postpartum Year

A NA study of Pregnancy and Hypertension, Pregnancy Induced, sponsored by University of Maryland, Baltimore.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06615076: Recruiting NA study of Pregnancy and Hypertension, Pregnancy Induced, sponsored by University of Maryland, Baltimore.

NCT06615076 is a NA study of Pregnancy and Hypertension, Pregnancy Induced that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 100 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06615076, a NA study of Pregnancy and Hypertension, Pregnancy Induced, is actively recruiting participants, sponsored by University of Maryland, Baltimore.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The United States is in the midst of a maternal mortality and morbidity crisis, with more than half of maternal deaths occurring within the first postpartum year. Patients with hypertensive disorders of pregnancy (HDP) and diabetes have been found to be particularly high-risk, as they have a significantly increased risk for the development of cardiovascular disease in the long-term postpartum period. Traditionally, postpartum care has consisted of a single office visit at six weeks postpartum. Recent research has suggested that postpartum care should be an ongoing process, tailored to each woman's specifics needs. The purpose of this research study is to evaluate the effectiveness of obstetric care providers as primary care providers for patients at increased risk of maternal morbidity and mortality in the full first postpartum year.

Primary Outcome

Diagnosis and treatment of hypertension through systolic blood pressure measurement by 12 months postpartum. An increase in systolic blood pressure would indicate continued and/or worsening hypertension.

Interventions

  • OTHER Postpartum Visits

Study Locations (1)

Maryland

  • University of Maryland, Baltimore - Baltimore

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-11-12
Est. Completion 2026-12
Phase NA
University of Maryland, Baltimore

560 total trials

What NCT06615076 shows while recruiting

NCT06615076 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (89% lower).

The record links to 3 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Postpartum Visits is the first listed.

NCT06615076 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT06615076 about?

NCT06615076 is a clinical study titled "Enhancing Care & Outcomes for Patients During the First Postpartum Year". The United States is in the midst of a maternal mortality and morbidity crisis, with more than half of maternal deaths occurring within the first postpartum year. Patients with hypertensive disorders of pregnancy (HDP) and diabetes have been found to be particularly high-risk, as they have a signifi...

What is the current status of trial NCT06615076?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-11-12. Estimated completion is 2026-12.

What conditions does trial NCT06615076 study?

This clinical trial studies the following conditions: Pregnancy, Hypertension, Pregnancy Induced, Postpartum Period.

What interventions are being tested in trial NCT06615076?

The interventions under investigation include: Postpartum Visits (OTHER).

Who is sponsoring clinical trial NCT06615076?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06615076 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06615076's enrollment target sits among peer trials

100 117th of 191 higher than 72 of 191 other Pregnancy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06615076, the US trial registry maintained by the National Library of Medicine. NCT06615076 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.